Multi-targeted antifolate (MTA): Pharmacokinetics of intraperitoneal administration in a rat model

European Journal of Surgical Oncology

Volumn 26, Issue 7, 2000, Pages 696-700

  Pestieau, S R ^a   Stuart, O A ^a   Sugarbaker, P H ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

Author keywords

Antifolates; Intraperitoneal chemotherapy; Mesothelioma; MTA

Indexed keywords

PEMETREXED;

ABDOMINAL WALL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; COLON CANCER; DRUG ADSORPTION; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MESENTERY LYMPH NODE; MESOTHELIOMA; NONHUMAN; PERITONEAL FLUID; PRIORITY JOURNAL; RAT;

EID: 0033636144     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2000.0983     Document Type: Article

References (11)

1. Antifoliates in clinical development
2. Preliminary results of a study with MTA (LY231514) in combination with cisplatin in patients with solid tumors
3. Intraperitoneal hyperthermia, a rat model
4. Rapid and simple method for the measurement of methotrexate and 7-hydroxymethotrexate in serum by high-performance liquid chromatography
5. Rapid quantitation of methotrexate and its metabolites in human serum, urine and bile, using solid-phase extraction and high-performance liquid chromatography
6. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer
7. A review of chemotherapy trials for malignant mesothelioma
8. Benign and malignant mesothelioma
9. Intraperitoneal chemotherapy for malignant peritoneal mesothelioma
10. Successful management of microscopic residual disease in large bowel cancer
11. Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery